| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,313 |
7,660 |
$320K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,013 |
1,657 |
$89K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,148 |
3,414 |
$69K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
241 |
223 |
$49K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,214 |
4,372 |
$44K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
976 |
475 |
$38K |
| 82947 |
|
11,016 |
5,770 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,546 |
891 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,129 |
662 |
$15K |
| 93880 |
|
161 |
123 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,709 |
1,465 |
$13K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
125 |
112 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
163 |
135 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
347 |
297 |
$10K |
| 93975 |
|
51 |
42 |
$7K |
| 95961 |
|
63 |
49 |
$6K |
| 93925 |
|
40 |
38 |
$6K |
| 95816 |
|
63 |
49 |
$5K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
4,776 |
2,646 |
$3K |
| 90674 |
|
239 |
210 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
270 |
190 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
250 |
192 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
51 |
$2K |
| 90756 |
|
132 |
68 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
136 |
27 |
$1K |
| 99442 |
|
251 |
133 |
$1K |
| 95957 |
|
65 |
49 |
$771.99 |
| 99307 |
|
157 |
67 |
$575.19 |
| 80305 |
|
85 |
66 |
$493.68 |
| 77085 |
|
15 |
13 |
$386.60 |
| 90688 |
|
35 |
32 |
$356.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,981 |
3,195 |
$341.68 |
| 99233 |
Prolong inpt eval add15 m |
45 |
12 |
$332.60 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
26 |
24 |
$275.10 |
| 99222 |
Initial hospital care, per day, moderate complexity |
14 |
12 |
$256.05 |
| J1940 |
Injection, furosemide, up to 20 mg |
158 |
112 |
$215.67 |
| 93050 |
|
70 |
22 |
$173.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,723 |
1,631 |
$113.19 |
| 86580 |
|
74 |
25 |
$87.45 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,824 |
2,468 |
$61.17 |
| 96138 |
|
16 |
14 |
$54.94 |
| J1815 |
Injection, insulin, per 5 units |
108 |
72 |
$17.24 |
| J1071 |
Injection, testosterone cypionate, 1 mg |
123 |
66 |
$0.65 |
| G0008 |
Administration of influenza virus vaccine |
97 |
80 |
$0.00 |
| 3008F |
|
213 |
128 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
272 |
50 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
79 |
64 |
$0.00 |
| 4040F |
|
12 |
12 |
$0.00 |
| J1000 |
Injection, depo-estradiol cypionate, up to 5 mg |
42 |
28 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
13 |
13 |
$0.00 |